NVO logo

Novo Nordisk A/S (NVO)

Profile

Full Name

Novo Nordisk A/S

Ticker Symbol

NVO

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

Denmark

IPO

April 30, 1981

Indexes

Not included

Website

http://www.novonordisk.com

Employees

76302

Key Details

Price

$66.06(+2.05%)

Market cap

$293.24B(Mega cap)

Last Dividend

$1.10

TTM Dividend yield

2.45%

Annual revenue

$42.13B(+24.95% YoY)

Annual EPS

$3.28(+21.45% YoY)

PE ratio

20.12

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$66.06
NVO price is $66.06

30-Day Relative Volume

0.97
NVO 30-day relative volume is 0.97

Price Performance

Price Most recent change

+2.05%
NVO price was up +2.05% on Apr 14, 2025

Price YTD change

-23.2%
NVO price is down -23.2% since January 1st

Price 1-year change

-46.94%
NVO price is down -46.94% year-on-year

Price 3-year change

+11.78%
NVO price is up +11.78% over the past 3 years

Price Range

Price All-time high

$148.15
NVO price is currently -55.41% below its historical high of $148.15

Price 3-year low

$47.51
NVO price is currently +39.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$293.24B
NVO market capitalization is $293.24 billion

Market cap 3-year change

+9.13%
NVO market capitalization is up +9.13% over the past 3 years

Market cap All-time high

$658.18B
NVO market capitalization is currently -55.45% below its historical high of $658.18 billion

Market cap sector rank

99.67%
NVO market capitalization is higher than 99.67% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.51%
NVO shares outstanding is down -0.51% year-on-year

Shares Outstanding 3-Year Change

-2.36%
NVO shares outstanding is down -2.36% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.72
NVO beta is 0.72

200-day SMA

$106.74
NVO price is currently -38.11% below its 200-day simple moving average

50-day SMA

$78.41
NVO price is currently -15.75% below its 50-day simple moving average

RSI

40.30
NVO 14-day relative strength index is 40.30

Volume

0.97
NVO 30-day relative volume is 0.97

ATR

$3.26
NVO average true range is $3.26

10-day Historical Volatility

68.89%
NVO 10-day historical volatility is 68.89%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.10
NVO last dividend was $1.10 per share, with an ex-dividend date of March 31, 2025

Next Dividend

-
NVO next dividend has not yet been announced

Dividend per share

Dividend per share

$1.45
NVO annual dividend per share is $1.45

Dividend per share Sector Rank

56.98%
NVO annual dividend per share is higher than 56.98% of companies in Healthcare sector

Dividend per share 1-Year Change

+40.17%
NVO annual dividend per share is up +40.17% year-on-year

Dividend per share 3-Year Change

+96.51%
NVO annual dividend per share is up +96.51% over the past 3 years

Dividend yield

Dividend yield

2.19%
NVO annual dividend yield is 2.19%

Dividend yield Sector Rank

50.59%
NVO annual dividend yield is higher than 50.59% of companies in Healthcare sector

Other

Payout ratio

43.71%
NVO annual payout ratio is 43.71%

Dividends paid

$6.40B
NVO annual dividends paid is $6.40 billion

Free cash flow

$10.11B
NVO annual free cash flow is $10.11 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$42.13B
NVO annual revenue is $42.13 billion

Revenue Analysts estimate

$349.57B
NVO annual revenue is currently -87.95% lower than the consensus analysts' forecast

Revenue 1-year change

+24.95%
NVO annual revenue is up +24.95% year-on-year

Revenue Sector rank

97.65%
NVO annual revenue is higher than 97.65% of companies in Healthcare sector

EPS

EPS

$3.28
NVO annual earnings per share is $3.28

EPS Analysts estimate

$26.71
NVO annual earnings per share is currently -87.71% lower than the consensus analysts' forecast

EPS 1-year change

+21.45%
NVO annual earnings per share is up +21.45% year-on-year

EPS Sector rank

94.04%
NVO annual earnings per share is higher than 94.04% of companies in Healthcare sector

Profit

Gross profit

$35.67B
NVO annual gross profit is $35.67 billion

Gross margin

84.67%
NVO annual gross profit margin is 84.67%

Operating profit

$18.62B
NVO annual operating income is $18.62 billion

Operating margin

44.19%
NVO annual operating profit margin is 44.19%

Net income

$14.65B
NVO annual net profit is $14.65 billion

Net margin

34.78%
NVO annual net profit margin is 34.78%

Expenses

Total expenses

$23.51B
NVO annual total expenses is $23.51 billion

Operating expenses

$17.05B
NVO annual total operating expenses is $17.05 billion

Cost of goods sold

$6.46B
NVO annual cost of goods sold is $6.46 billion

Selling, general & administrative expenses

$9.78B
NVO annual SGA is $9.78 billion

Depreciation and amortization

$1.24B
NVO annual depreciation & amortization is $1.24 billion

Interest expense

$237.95M
NVO annual interest expense is $237.95 million

Income tax

$3.80B
NVO annual income tax is $3.80 billion

EBIT & EBITDA

EBIT

$18.69B
NVO annual earnings before interest & taxes is $18.69 billion

EBITDA

$19.93B
NVO annual EBITDA is $19.93 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$64.99B
NVO annual total assets is $64.99 billion

Non current assets

$42.54B
NVO annual long term assets is $42.54 billion

Current assets

$22.45B
NVO annual total current assets is $22.45 billion

Cash and cash equivalents

$2.18B
NVO annual cash & cash equivalents is $2.18 billion

Accounts receivable

$10.04B
NVO annual accounts receivable is $10.04 billion

Inventory

$5.70B
NVO annual inventory is $5.70 billion

Liabilities

Total liabilities

$44.97B
NVO annual total liabilities is $44.97 billion

Long term liabilities

$14.62B
NVO annual total long term liabilities is $14.62 billion

Current liabilities

$30.35B
NVO annual total current liabilities is $30.35 billion

Accounts payable

$4.02B
NVO annual accounts payable is $4.02 billion

Debt

Total debt

$14.34B
NVO annual total debt is $14.34 billion

Total debt 1-year change

+257.65%
NVO annual total debt is up +257.65% year-on-year

Long term debt

$12.51B
NVO annual long term debt is $12.51 billion

Short term debt

$1.83B
NVO annual short term debt is $1.83 billion

Equity & Capital

Shareholders equity

$20.02B
NVO annual stockholders equity is $20.02 billion

Book value

$20.02B
NVO annual book value is $20.02 billion

Retained earnings

$20.15B
NVO annual retained earnings is $20.15 billion

Working capital

-$7.90B
NVO annual working capital is -$7.90 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$17.55B
NVO annual cash flow from operations is $17.55 billion

Cash from operations 1-year change

+11%
NVO annual cash flow from operations is up +11% year-on-year

Cash from investing

-$18.70B
NVO annual cash flow from investing activities is -$18.70 billion

Cash from investing 1-year change

-193.47%
NVO annual cash flow from investing activities is down -193.47% year-on-year

Cash from financing

$1.27B
NVO annual cash flow from financing activities is $1.27 billion

Cash from financing 1-year change

+113.82%
NVO annual cash flow from financing activities is up +113.82% year-on-year

CAPEX

CAPEX

$7.44B
NVO annual capital expenditures is $7.44 billion

CAPEX 1-year change

+31.82%
NVO annual capital expenditures is up +31.82% year-on-year

Free Cash Flow

Free cash flow

$10.11B
NVO annual free cash flow is $10.11 billion

Free cash flow 1-year change

-0.57%
NVO annual free cash flow is down -0.57% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

84.67%
NVO annual gross profit margin is 84.67%

Operating margin

44.19%
NVO annual operating profit margin is 44.19%

Net margin

34.78%
NVO annual net profit margin is 34.78%

ROA & ROE

ROA

26.24%
NVO annual return on assets is 26.24%

ROE

81.76%
NVO annual return on equity is 81.76%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

20.12
NVO price to earnings ratio is 20.12

PE ratio Sector rank

38.73%
NVO price to earnings ratio is higher than 38.73% of companies in Healthcare sector

PB Ratio

PB ratio

14.65
NVO price to book ratio is 14.65

PB ratio Sector rank

95.64%
NVO price to book ratio is higher than 95.64% of companies in Healthcare sector

PS Ratio

PS ratio

6.97
NVO price to sales ratio is 6.97

PS ratio Sector rank

73.72%
NVO price to sales ratio is higher than 73.72% of companies in Healthcare sector

Enterprise value

Enterprise value

$305.40B
NVO enterprise value is $305.40 billion

Enterprise value Sector rank

99.67%
NVO enterprise value is higher than 99.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.03
NVO EV/EBITDA is 14.03

EV/EBITDA Sector rank

87.04%
NVO EV/EBITDA is higher than 87.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.74
NVO annual current ratio is 0.74

Quick ratio

0.55
NVO annual quick ratio is 0.55

Leverage

Debt to equity

0.67
NVO annual debt to equity ratio is 0.67

Interest coverage ratio

78.56
NVO annual interest coverage ratio is 78.56

Risk & Stability

Piotroski F-Score

5
NVO piotroski f-score is 5

Altman Z-Score

5.80
NVO altman z-score is 5.80

Analyst ratings

Recent major analysts updates

Jan 8, 25 UBS
Buy
Dec 23, 24 BMO Capital
Outperform
Nov 6, 24 Cantor Fitzgerald
Overweight
Oct 22, 24 Citigroup
Buy
Oct 17, 24 BMO Capital
Outperform
Oct 16, 24 Barclays
Overweight
Oct 14, 24 BMO Capital
Market Perform
Oct 10, 24 Jefferies
Buy
Oct 10, 24 Cantor Fitzgerald
Overweight
Sep 20, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

ABBV logo
AbbVie (ABBV)
ABT logo
Abbott Laboratories (ABT)
NVS logo
Novartis AG (NVS)
JNJ logo
Johnson & Johnson (JNJ)
AZN logo
AstraZeneca (AZN)
MRK logo
Merck & Co (MRK)
ISRG logo
Intuitive Surgical (ISRG)
TMO logo
Thermo Fisher Scientific (TMO)
AMGN logo
Amgen (AMGN)
  • What is the ticker symbol for Novo Nordisk A/S?
  • Does Novo Nordisk A/S pay dividends?
  • What sector is Novo Nordisk A/S in?
  • What industry is Novo Nordisk A/S in?
  • What country is Novo Nordisk A/S based in?
  • When did Novo Nordisk A/S go public?
  • Is Novo Nordisk A/S in the S&P 500?
  • Is Novo Nordisk A/S in the NASDAQ 100?
  • Is Novo Nordisk A/S in the Dow Jones?
  • When was Novo Nordisk A/S's last earnings report?
  • When does Novo Nordisk A/S report earnings?

What is the ticker symbol for Novo Nordisk A/S?

The ticker symbol for Novo Nordisk A/S is NYSE:NVO

Does Novo Nordisk A/S pay dividends?

Yes, Novo Nordisk A/S pays dividends. The last payment was $1.10, with an ex-dividend date on March 31, 2025

What sector is Novo Nordisk A/S in?

Novo Nordisk A/S is in the Healthcare sector

What industry is Novo Nordisk A/S in?

Novo Nordisk A/S is in the Drug Manufacturers - General industry

What country is Novo Nordisk A/S based in?

Novo Nordisk A/S is headquartered in Denmark

When did Novo Nordisk A/S go public?

Novo Nordisk A/S's initial public offering (IPO) was on April 30, 1981

Is Novo Nordisk A/S in the S&P 500?

No, Novo Nordisk A/S is not included in the S&P 500 index

Is Novo Nordisk A/S in the NASDAQ 100?

No, Novo Nordisk A/S is not included in the NASDAQ 100 index

Is Novo Nordisk A/S in the Dow Jones?

No, Novo Nordisk A/S is not included in the Dow Jones index

When was Novo Nordisk A/S's last earnings report?

Novo Nordisk A/S's most recent earnings report was on Feb 5, 2025

When does Novo Nordisk A/S report earnings?

The next expected earnings date for Novo Nordisk A/S is May 7, 2025
On this page